MINGSIGHT PHARMACEUTICALS
Mingsight, an ophthalmic medical drug developer, has initiated a clinical trial of the original innovative drug MS-553 in patients with diabetic retinopathy. This study is the world's first clinical trial of MS-553 in this indication. In the field of CLL treatment, MS-533 can be used alone or in combination with ibrutinib, BCL-2, etc., initially showing outstanding clinical value and market potential in the treatment of patients with C481S and PLCG2 mutations; in the field of DME treatment, MS-533 can be taken orally to achieve enrichment in the retina of the fundus, avoiding the need for vitreous injection of drugs such as ranibizumab, and clinical data such as BCVA/CRT of patients also initially show the efficacy of the product.
MINGSIGHT PHARMACEUTICALS
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2011-09-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.mingsight.com
Total Employee:
11+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
20 M USD
Similar Organizations
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Ciclofilin Pharmaceuticals
Ciclofilin Pharmaceuticals is a biopharmaceutical company specializing in development of cyclophilin inhibitors.
Elitra Pharmaceuticals
Elitra Pharmaceuticals in San Diego, CA is a private company categorized under Pharmaceutical Preparations.
Merck Sharp & Dohme
Merck Sharp & Dohme is a pharmaceutical company engaged in researching, discovering and developing pharmaceutical drugs.
MycroDose Therapeutics
Mycrodose Therapeutics is a pharmaceutical company specialized in the development of advanced drug delivery (ADD) systems
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Sprout Pharmaceuticals
Sprout Pharmaceuticals is a medical company that develops products for the treatment of female sexual dysfunction.
Current Employees Featured
Founder
Investors List
Kaitai Capital
Kaitai Capital investment in Series B - Mingsight Pharmaceuticals
Official Site Inspections
http://www.mingsight.com
- Host name: a16e665f42988324c.awsglobalaccelerator.com
- IP address: 76.223.105.230
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108

More informations about "Mingsight Pharmaceuticals"
MingSight
MingSight Pharmaceuticals is a clinical stage company focused on the development of a new generation, selective inhibitor of protein kinase C (PKC) beta, MS-553. A Novel, Potent and Selective PKC Inhibitor. Major …See details»
Mingsight Pharmaceuticals - Crunchbase Company Profile
Organization. Mingsight Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Mingsight, an ophthalmic medical …See details»
Mingsight Pharmaceuticals, Inc. - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Mingsight Pharmaceuticals, Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
Mingsight Pharmaceuticals Company Profile - Office Locations
Mingsight Pharmaceuticals is a company that specializes in protein kinase C (PKC) inhibitors. It offers MS-553 inhibitors for chronic lymphocytic leukemia (CLL) and diabetic macular edema …See details»
MingSight - Overview, News & Similar companies | ZoomInfo.com
Who is MingSight. MingSight is a clinical stage company focused on developing differentiated, novel therapies for serious diseases including B-cell malignancies, dia betic macular edema, …See details»
Mingsight Pharmaceuticals - Funding, Financials, Valuation
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. ... How …See details»
Mingsight Pharmaceuticals Headquarters and Office Locations
Mingsight Pharmaceuticals is headquartered in San Diego, 11318 Village Ridge Rd, United States, and has 1 office location.See details»
MingSight - Company Profile - Tracxn
Feb 22, 2025 MingSight. has raised a total funding of $20M over 1 round. What are the most recent funding rounds of MingSight? Its latest funding round was a Series A round on Nov 10, …See details»
Mingsight Pharmaceuticals - Contacts, Employees, Board Members ...
Mingsight Pharmaceuticals is a pharmaceutical company engaged in developing ophthalmic medical drugs. New. Resources. Advanced Search ... Experience the new Crunchbase, …See details»
MingSight Pharmaceuticals - VentureRadar
MingSight Pharmaceuticals is a clinical stage company focused on the development of a new generation, selective inhibitor of protein kinase C (PKC) beta, MS-553.Major improvements in …See details»
Mingsight Pharmaceuticals Inc. - BioCentury Company Profiles
Oct 25, 2010 Mingsight Pharmaceuticals Inc. - BioCentury Company Profiles for the biopharma industrySee details»
MingSight Pharmaceuticals, Inc. Overview - SignalHire
Organization Website: mingsight.com : MingSight Pharmaceut... industries Pharma: MingSight Pharmaceut... Employees Size 1-10 employees: MingSight Pharmaceuticals, Inc. …See details»
MingSight Pharmaceuticals - Products, Competitors, Financials ...
MingSight Pharmaceuticals is a clinical stage company focused on developing selective inhibitors for protein kinase C (PKC), particularly in the pharmaceutical industry. Use the CB Insights …See details»
MingSight Pharmaceuticals - PitchBook
MingSight Pharmaceuticals General Information Description. Researcher and developer of innovative drugs intended to cure diabetic retinopathy and related disease. The company has …See details»
MingSight Pharmaceuticals, Inc. - Drug pipelines, Patents
Mar 7, 2025 Explore MingSight Pharmaceuticals, Inc. with its drug pipeline, therapeutic area, technology platform, 9 clinical trials, 1 news, Disease Domain:Hemic and Lymphatic Diseases, …See details»
MingSight Completes a New Round of Financing to Accelerate …
Nov 12, 2021 MingSight is a clinical stage company focused on developing differentiated, novel therapies for serious diseases including B-cell malignancies, diabetic macular edema, and …See details»
MingSight - CoBee Company Profile & Funding Rounds
Mingsight, an ophthalmic medical drug developer, has initiated a clinical trial of the original innovative drug MS-553 in patients with diabetic retinopathy. This study is the world&s;s first …See details»
MingSight Pharmaceuticals | CipherBio
Explore MingSight Pharmaceuticals's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Series B - Mingsight Pharmaceuticals - 2021-11-09 - Crunchbase
Nov 9, 2021 Mingsight Pharmaceuticals raised $20000000 on 2021-11-09 in Series B. Weixin Official Accounts Platform — Mingsight completed the Pre-B round of financing of nearly 20 …See details»
MingSight Pharmaceuticals, Inc. (深圳明赛瑞霖药业有限公司) - 药 …
了解MingSight Pharmaceuticals, Inc. (深圳明赛瑞霖药业有限公司)公司的药物管线,治疗领域,技术平台,以及它的9项临床试验, 1篇新闻,疾病领域:血液及淋巴系统疾病,肿瘤,免疫系统疾 …See details»